Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Insight into Infectious Diseases Could Lead to Preventive Vaccines for Some Rheumatic Illnesses

Thomas R. Collins  |  Issue: August 2016  |  August 11, 2016

“Porphyromonas gingivalis is the only bacterium known to do that,” Dr. Lorber said. “The idea here is that this organism, in genetically susceptible individuals, makes citrullinated antigens that then serve as systemic immunogens, resulting in rheumatoid arthritis.”

The Microbiome

Research in heart disease has found that, after inoculating human cells with Chlamydophila pneumonia, the bacterium up-regulates genes with important pro-inflammatory functions, including those associated with atherosclerosis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another shift is occurring, too, Dr. Lorber said. Ever since anthrax was proved to be caused by bacteria, more than a hundred years ago, there was a belief that one disease was caused by one organism. But that might not always be the case, new evidence is showing.

“It may not be one organism,” Dr. Lorber said. “It may be populations of organisms or relative proportions of populations. So maybe it’s not infection in the traditional sense. Maybe it’s an imbalance of the microbiome,” or “dysbiosis.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For example, using new tools, such as 16S sequencing—a way to assess the taxonomy in difficult-to-study microbiomes—in people with RA and in controls, researchers have found that the presence of Prevotella copri bacteria, with an associated reduction in the normal Bacteroidetes population, is correlated strongly with new onset of RA.2

Scientists are also shedding light on the so-called “gut–brain axis,” signaling in which the gut talks to the brain through neural mechanisms, including the vagus nerve, as well as endocrine mechanisms, immune mechanisms and metabolic mechanisms.

Germ-free mice that are deliberately stressed develop higher levels of stress hormone, as well as lower levels than normal mice of a brain protein that modulates synaptic growth and transmission.3

“If you recolonize with normal mice gut flora, you can reverse that and they lower levels of stress hormones,” Dr. Lorber said.

Obese people, researchers have found, have more Bacteroidetes and fewer Firmicutes than controls who are lean.4

“It turns out that obese individuals who complain all the time (that), ‘I ate the same thing you ate—why don’t you get fat?’ may have a good explanation,” Dr. Lorber said. “They may have more efficient energy harvesting from what they eat.”

‘I think it’s very likely that as time goes by we will establish firmer links between transmissible agents & chronic illness. That’s exciting because it opens the opportunity for prevention through immunization.’ —Bennett Lorber, MD, MACP

Future Possiblities

All of these discoveries are cause for great optimism, he said.

“I really think we may soon be treating neuropsychiatric disorders with probiotics,” Dr. Lorber said. “The hard part is being able to figure out which probiotic is going to do the trick. But just imagine this.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:2016 State-of-the-Art Clinical SymposiumImmunizationinfectious diseasepreventiveResearchRheumatic DiseaseTreatmentvaccine

Related Articles

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA

    September 17, 2019

    Researchers know human leukocyte antigen (HLA) molecules affect susceptibility to disease in general, and immunological disease in particular. In the case of ankylosing spondylitis (AS), the risk is primarily associated with HLA-B27, with smaller effects from other HLA alleles. Current thinking is that AS is caused by the presence of a genetically primed host because…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences